HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function

Current HIV Research

Volumn 12, Issue 1, 2014, Pages 50-59

  So Armah, Kaku A ^a   Chang, Joyce ^b,c   Alcorn, Charles ^c   Lo Re, Vincent ^d   Baker, Jason V ^e   Tracy, Russell ^f   Butt, Adeel A ^b,g,h   Agan, Brian K ⁱ   Rimland, David ^j   Gibert, Cynthia L ^k   Goetz, Matthew B ^l   Oursler, Krisann K ^m   Rodriguez Barradas, Maria C ⁿ   Kuller, Lewis H ^c   Brown, Sheldon T ^g,o   Stein, James H ^p   Skanderson, Melissa ^g   Justice, Amy C ^a,g   Freiberg, Matthew S ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

ⁱ UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m BALTIMORE VA MEDICAL CENTER   (United States)

ⁿ BAYLOR COLLEGE OF MEDICINE   (United States)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

more..

Author keywords

Chronic diseases of aging; Clinical biomarkers; HIV infection; Lipids

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; VIRUS RNA;

ADULT; ANALYSIS; BLOOD; BLOOD PRESSURE; CD4 LYMPHOCYTE COUNT; COMPLICATION; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTENSION; KIDNEY DISEASE; LIVER DISEASE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; VETERAN;

ADULT; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; KIDNEY DISEASES; LIPIDS; LIVER DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RNA, VIRAL; VETERANS;

EID: 84905662902     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X1201140716101512     Document Type: Article

References (31)

1. Butt A. Epidemiology of Liver Disease in Human Immunodeficiency Virus-Infected Persons. 2012.
2. Phair J, Palella F. Renal disease in HIV-infected individuals. Curr Opin HIV AIDS 2011; 6(4): 285-9.
3. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34(1): 121-30.
4. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97(6): 425-432.
5. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355(22): 2283-96.
6. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology and therapeutics 2001; 69(3): 89-95.
7. Anastos K, Lu D, Shi Q, et al. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr 2007; 45(1): 34-42.
8. Riddler SA, Li X, Chu H, et al. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy. HIV Med 2007; 8(5): 280-7.
9. Van Leth F, Phanuphak P, Stroes E, et al. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy- naive patients infected with HIV-1. PLoS Med 2004; 1(1): e19.
10. Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003; 289(22): 2978-82.
11. Achhra AC, Amin J, Law MG, et al. Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion - the Health In Men (HIM) Biomarker sub-study. Antivir Ther 2012.
12. Redd AD, Eaton KP, Kong X, et al. C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation. J Acquir Immune Defic Syndr 2010; 54(5): 556-9.
13. Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses 2006; 22(1): 14-21.
14. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a virtual cohort using the National VA Health Information System. Med Care 2006; 44(8 Suppl 2): S25-30.
15. Snyder N, Gajula L, Xiao SY, et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 2006; 40(6):535-42.
16. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43(6):1317-25.
17. Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC. Risk of diabetes in HIV infected veterans pre- and post- HAART and the role of HCV coinfection. Hepatology 2004; 40(1): 115-9.
18. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. Aids 2005; 19 Suppl 3: S99-105.
19. Kraemer KL, McGinnis KA, Skanderson M, et al. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care 2006; 44(8 Suppl 2): S44-51.
20. Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2001; 26(1): 28-35.
21. van der Lelie J, Lange JM, Vos JJ, van Dalen CM, Danner SA, von dem Borne AE. Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection. Br J Haematol 1987; 67(1): 109-14.
22. Jahoor F, Gazzard B, Phillips G, et al. The acute-phase protein response to human immunodeficiency virus infection in human subjects. Am J Physiol 1999; 276(6 PART 1): E1092-1098.
23. Bostian KA, Blackburn BS, Wannemacher RW, Jr., McGann VG, Beisel WR, Dupont HL. Sequential changes in the concentration of specific serum proteins during typhoid fever infection in man. J Lab Clin Med 1976; 87(4): 577-85.
24. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74(5): 1045-52.
25. Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA internal medicine 2013; 173(8): 614-22.
26. Harris RJ, Sterne JA, Abgrall S, et al. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther 2008; 13(8): 959-67.
27. Justice AC, Freiberg MS, Tracy R, et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis 2012; 54(7): 984-94.
28. Torre D, Pugliese A. Platelets and HIV-1 infection: old and new aspects. Curr HIV Res 2008; 6(5): 411-8.
29. Zauli G, Re MC, Davis B, et al. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992; 79(10): 2680-7.
30. Zucker-Franklin D, Termin CS, Cooper MC. Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1). Am J Pathol 1989; 134(6): 1295-303.
31. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53(11): 1120-6.